[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"notifications-list":3,"$fgfwo5ld0v68m":5},{"data":4},[],{"data":6,"error":10},{"id":7,"documentId":8,"slug":9,"name":9,"proprietary_name":10,"non_proprietary_name":10,"is_proprietary":10,"active_ingredient":10,"administration_route":10,"available_strength":10,"dosage_form":10,"dose_schedule":10,"drug_unit":10,"is_available_generically":10,"mechanism_of_action":10,"overdosage":10,"warning":10,"species":11,"citations":12,"dose_schedules":23,"available_strengths":31,"label_statements":36,"drug_classes":41,"specialties":47,"medical_conditions":48,"animal_species":54},1772,"m9o83usfemjjt8md2uor0xa3","pirlimycin",null,[],[13,19],{"source":14,"licence":15,"source_url":16,"harvested_by":17,"retrieved_at":18},"FDA Green Book","US public domain","https:\u002F\u002Fanimaldrugsatfda.fda.gov\u002Fadafda\u002Fapp\u002Fsearch\u002Fpublic\u002FingredientsInformationExcel\u002FSection2ActiveIngredients","load-reference-corpus.cjs","2026-09-07",{"source":20,"licence":21,"source_url":22,"harvested_by":17,"retrieved_at":18},"UK VMD PID","OGL v3.0","https:\u002F\u002Fwww.vmd.defra.gov.uk\u002Fproductinformationdatabase\u002Fdownloads\u002Fvmd_productinformationdatabase.xlsx",[24],{"id":25,"dose_text":26,"species":27,"administration_route":28,"limitation":29,"source_label":30},12838,"Infuse one (1) syringe (50 milligrams) in each infected quarter, repeated once after 24 hours. Daily treatment may be repeated at 24-hour intervals for up to 8 consecutive days.","Lactating Cows","Intramammary","For intramammary infusion in lactating cows only. Federal law restricts this drug to use by or on the order of a licensed veterinarian.","Pirsue® Sterile Solution",[32],{"id":33,"strength_text":34,"dosage_form":35,"proprietary_name":30,"species":27,"source_label":30},11141,"Each 10-milliliter syringe contains 50 milligrams (5 mg\u002FmL) of pirlimycin (as pirlimycin hydrochloride).","Solution-Sterile",[37],{"id":38,"kind":39,"statement":40,"species":27,"limitation":29,"source_label":30},18726,"indication","For the treatment of clinical and subclinical mastitis, caused by Staphylococcus species, such as Staphylococcus aureus; and Streptococcus species, such as Streptococcus agalactiae, Streptococcus dysgalactiae, and Streptococcus uberis.",[42],{"id":43,"documentId":44,"slug":45,"name":46},759,"kx7vbiroed2vtoz0tc26ba5z","lincosamides","Lincosamides",[],[49],{"id":50,"documentId":51,"slug":52,"title":53},93,"y9y33g9pxsm3uyf6u9o7kdpf","mastitis","Mastitis",[]]